Classification and Natural History of the Neuronal Ceroid Lipofuscinoses

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Child Neurology

• Publication date

  2013-07-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/0883073813494268PMID 23838030PMCID PMC3979348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates.

  2013cited by this paper
• Do females with juvenile ceroid lipofuscinosis (Batten disease) have a more severe disease course? The Danish experience.

  2013cited by this paper
• New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses

  2012cited by this paper
• Females experience a more severe disease course in batten disease

  2012cited by this paper
• Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease)

  2011cited by this paper
• NCL nomenclature and classification

  2011cited by this paper
• Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6.

  2011cited by this paper
• Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease)

  2011cited by this paper
• Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease)

  2010cited by this paper
• CLN5 mutations are frequent in juvenile and late-onset non-Finnish patients with NCL

  2010cited by this paper
• Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis.

  2009cited by this paper
• Adult neuronal ceroid lipofuscinosis caused by deficiency in palmitoyl protein thioesterase 1

  2007cited by this paper
• Cathepsin D deficiency is associated with a human neurodegenerative disorder.

  2006cited by this paper
• Glycosaminoglycans Modulate Activation, Activity, and Stability of Tripeptidyl-peptidase I in Vitro and in Vivo*

  2005cited by this paper
• Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses

  2005cited by this paper
• Pediatric neuro-ophthalmology

  2004cited by this paper
• Neuroradiological Findings (MRS, MRI, SPECT) in Infantile Neuronal Ceroid-Lipofuscinosis (Infantile CLN1) at Different Stages of the Disease

  2004cited by this paper
• Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies.

  2004cited by this paper
• The Neuronal Ceroid–Lipofuscinoses

  2003cited by this paper
• Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations.

  2002cited by this paper
• Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse.

  2002cited by this paper
• Biochemical analysis of mutations in palmitoyl-protein thioesterase causing infantile and late-onset forms of neuronal ceroid lipofuscinosis.

  2001cited by this paper
• Adult neuronal ceroid lipofuscinosis with palmitoyl‐protein thioesterase deficiency: First adult‐onset patients of a childhood disease

  2001cited by this paper
• Turkish variant late infantile neuronal ceroid lipofuscinosis (CLN7) may be allelic to CLN8.

  2001cited by this paper
• Northern epilepsy, a new member of the NCL family

  2000cited by this paper
• Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S.

  1998cited by this paper
• Palmitoyl-protein thioesterase deficiency in a novel granular variant of LINCL.

  1998cited by this paper
• Childhood neuronal ceroid-lipofuscinoses in Argentina.

  1995cited by this paper
• Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis

  1995cited by this paper
• Kufs' disease: a critical reappraisal.

  1988cited by this paper
• Kufs disease: clinical features and forms.

  1988cited by this paper
• A Variant of Jansky-Bielschowsky Disease

  1982cited by this paper
• A dominant form of neuronal ceroid-lipofuscinosis

  1981cited by this paper
• Clinical, morphological, and biochemical investigations on a patient with an unusual form of neuronal ceroid-lipofuscinosis

  1979cited by this paper
• Infantile type of so-called neuronal ceroid-lipofuscinosis.

  1974cited by this paper
• Infantile Type of So‐called Neuronal Ceroid‐lipofuscinosis

  1973cited by this paper
• Infantile type of so-called neuronal ceroid-lipofuscinosis. 2. Morphological and biochemical studies.

  1973cited by this paper
• A dominant form of neuronal ceroid-lipofuscinosis.

  1971cited by this paper
• Über eine Spätform der amaurotischen Idiotie und ihre heredofamiliären Grundlagen

  1925cited by this paper
• über familiäre amaurotische Idiotie und verwandte Krankheitsbilder.

  1906cited by this paper
• Cerebral degeneration, with symmetrical changes in the maculae, in two members of a family

  year unknowncited by this paper

• Neurodevelopmental and Psychiatric Disorders and the Use of Psychotropic Medications in a National Sample of Individuals With Juvenile Neuronal Ceroid Lipofuscinosis.

  2026cites this paper
• Open-label evaluation of oral trehalose in patients with neuronal ceroid lipofuscinoses

  2025cites this paper
• Longitudinal Exploration of Auditory Sensory-Perceptual Processing in CLN3 Disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): A High-Density Auditory Evoked Potential (AEP) Study

  2025influential citation
• Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten disease

  2025cites this paper
• Research priorities for the neuronal ceroid lipofuscinoses.

  2025cites this paper
• Is Miglustat an Effective Treatment for CLN3 (Batten) Disease?

  2025cites this paper
• A timeline of symptom onset and disease progression in CLN3 disease

  2025cites this paper
• The Wechsler intelligence scale for children, fourth and fifth editions perform comparably in children with Batten disease

  2025cites this paper
• A clinical case of neuronal ceroid there are 3 types of lipofuscinosis

  2025cites this paper
• Case Report: The window that closed too soon: lessons from a late CLN2 diagnosis and death of a 9-year-old boy

  2025cites this paper
• Downregulation of AKT-mediated p27Kip1 phosphorylation with shift to sphingomyelin synthesis in CLN3 disease

  2025cites this paper
• Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten disease

  2025cites this paper
• Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United Kingdom

  2025influential citation
• Neuronal ceroid lipofuscinosis type 11 in early childhood

  2025cites this paper
• The Wechsler Intelligence Scale for Children, fourth and fifth editions perform comparably in children with Batten Disease

  2025cites this paper
• Sex-specific and age-related progression of auditory neurophysiological deficits in the Cln3 mouse model of Batten disease

  2025cites this paper
• Clinical and Molecular Characteristics of Neuronal Ceroid Lipofuscinosis in Saudi Arabia.

  2024cites this paper
• A Rare Case of CLN3-associated Isolated Retinal Degeneration with Macular Oedema

  2024cites this paper
• Protein sequence analysis in the context of drug repurposing

  2024cites this paper
• The parent and family impact of CLN3 disease: an observational survey-based study

  2024influential citation
• The Psychiatric Care of Children and Young Adults With Neurodegenerative Diseases.

  2024cites this paper
• Progressive Myoclonus Epilepsy: A Scoping Review of Diagnostic, Phenotypic and Therapeutic Advances

  2024influential citation
• Assessing the integrity of auditory sensory memory processing in CLN3 disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): an auditory evoked potential study of the duration-evoked mismatch negativity (MMN)

  2024cites this paper
• Adult-onset Kufs disease

  2023cites this paper
• Inborn Errors of Metabolism with Ataxia: Current and Future Treatment Options

  2023cites this paper
• Assessing the integrity of auditory sensory memory processing in CLN3 disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): An auditory evoked potential study of the duration-evoked mismatch negativity (MMN)

  2023cites this paper
• Protracted CLN3 Batten disease in mice that genetically model an exon-skipping therapeutic approach

  2023cites this paper
• Rare adult neuronal ceroid lipofuscinosis associated with CLN6 gene mutations: A case report

  2023cites this paper
• A Rare Case of Neuronal Ceroid Lipofuscinosis-Type 1 (NCL-1) with Vitamin D-Dependent Rickets-Type 1 (VDDR-1), Complex 1 Mitochondrial Deficiency, and Mixed Variant—Checkerboard and Phylloid Type of Pigmentary Mosaicism

  2023cites this paper
• Progressive myoclonus and neuroregression – a dreadful combination

  2023cites this paper
• Sjögren: unique surname, two men, four syndromes and one disease

  2023cites this paper
• Clinical and genetic characterization of neuronal ceroid lipofuscinoses (NCLs) in 29 Iranian patients: identification of 11 novel mutations

  2023cites this paper
• Identification of a mitochondrial targeting sequence in cathepsin D and its localization in mitochondria

  2023cites this paper
• New Indications for Hematopoietic Stem Cell Gene Therapy in Lysosomal Storage Disorders

  2022cites this paper
• Neuronal Ceroid Lipofuscinosis: The Multifaceted Approach to the Clinical Issues, an Overview

  2022cites this paper
• Towards Understanding Behaviour and Emotions of Children with CLN3 Disease (Batten Disease): Patterns, Problems and Support for Child and Family

  2022cites this paper
• Clinical and genetic characterization of a cohort of 97 CLN6 patients tested at a single center

  2022cites this paper
• Emerging Perspectives on Gene Therapy Delivery for Neurodegenerative and Neuromuscular Disorders

  2022cites this paper
• Sex-split analysis of pathology and motor-behavioral outcomes in a mouse model of CLN8-Batten disease reveals an increased disease burden and trajectory in female Cln8mnd mice

  2022cites this paper
• Top-down and bottom-up propagation of disease in the neuronal ceroid lipofuscinoses

  2022cites this paper
• Long-term progression of retinal degeneration in a preclinical model of CLN7 Batten disease as a baseline for testing clinical therapeutics

  2022cites this paper
• Clinical case of neuronal ceroid lipofuscinosis type II in a child

  2022cites this paper
• Neuronal ceroïd‐lipofuscinosis: Clinical, electroencephalographic, imaging, and genetic study of a maghrebian series

  2022cites this paper
• Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis

  2022cites this paper
• Brain transcriptome analysis of a CLN2 mouse model as a function of disease progression

  2021cites this paper
• Lysosomal Storage Disorders

  2021cites this paper
• Retinal Phenotype of Patients With Isolated Retinal Degeneration Due to CLN3 Pathogenic Variants in a French Retinitis Pigmentosa Cohort.

  2021cites this paper
• Cathepsin D Variants Associated With Neurodegenerative Diseases Show Dysregulated Functionality and Modified α-Synuclein Degradation Properties

  2021cites this paper
• Paroxysmal sympathetic hyperactivity following status epilepticus in a 22-year-old with Juvenile Neuronal Ceroid Lipofuscinosis: A case report

  2021influential citation
• Disruption of morphogenic and growth pathways in lysosomal storage diseases.

  2021cites this paper
• Batten's Disease: A Seizure Disorder's Battle for Diagnosis

  2021cites this paper
• Management of CLN1 Disease: International Clinical Consensus.

  2021cites this paper
• A diagnostic confidence scheme for CLN3 disease

  2021cites this paper
• Patient-Derived Induced Pluripotent Stem Cell Models for Phenotypic Screening in the Neuronal Ceroid Lipofuscinoses

  2021influential citation
• A novel CLN5 mutation in Turkish patient with variant late-onset neuronal ceroid lipofuscinosis and recurrent fractures that causes severe morbidity

  2021cites this paper
• A Novel CLN6 Variant Associated With Juvenile Neuronal Ceroid Lipofuscinosis in Patients With Absence of Visual Loss as a Presenting Feature

  2021cites this paper
• Molecular networking in the neuronal ceroid lipofuscinoses: insights from mammalian models and the social amoeba Dictyostelium discoideum

  2020cites this paper
• A Proposed Diagnostic Algorithm for Inborn Errors of Metabolism Presenting With Movements Disorders

  2020cites this paper
• Neuronal ceroid lipofuscinosis in the Russian population: Two novel mutations and the prevalence of heterozygous carriers

  2020cites this paper
• A Case Report on the Challenging Diagnosis of Neuronal Ceroid Lipofuscinosis Type 2 (CLN2)

  2020cites this paper
• Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients

  2020cites this paper
• The CLN3 Disease Staging System

  2020cites this paper
• Neuronal Ceroid Lipofuscinosis: Potential for Targeted Therapy

  2020cites this paper
• Children and Young People's Continuing Care

  2020cites this paper
• VACUOLAR STORAGE DISEASE IN LAGOTTO ROMAGNOLO DOGS: PATHOLOGY, AUTOPHAGY AND EXTRACELLULAR VESICLES

  2020cites this paper
• An iPSC-Derived Neuron Model of CLN3 Disease Facilitates Small Molecule Phenotypic Screening.

  2020cites this paper
• Movement Disorders and Inherited Metabolic Disorders

  2020cites this paper
• A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative disease.

  2020cites this paper
• Small Molecules that Rescue Multiple Phenotypic Aberrations in an iPSC-Derived Neuron Model of CLN3 Disease

  2020cites this paper
• Lafora body disease: a case of progressive myoclonic epilepsy

  2020cites this paper
• Juvenile Batten Disease (CLN3): Detailed Ocular Phenotype, Novel Observations, Delayed Diagnosis, Masquerades, and Prospects for Therapy

  2019cites this paper
• Next-Generation Sequencing Analysis Reveals Novel Pathogenic Variants in Four Chinese Siblings With Late-Infantile Neuronal Ceroid Lipofuscinosis

  2019cites this paper
• Global Brain Transcriptome Analysis of a Tpp1 Neuronal Ceroid Lipofuscinoses Mouse Model

  2019influential citation
• Current therapies and therapeutic decision making for childhood‐onset movement disorders

  2019cites this paper
• An update on the progress of preclinical models for guiding therapeutic management of neuronal ceroid lipofuscinosis

  2019cites this paper
• Therapeutic landscape for Batten disease: current treatments and future prospects

  2019cites this paper
• Batten disease

  2019cites this paper
• A multimodal approach to identify clinically relevant parameters to monitor disease progression in a preclinical model of neuropediatric disease

  2019cites this paper
• Aspects génétiques des épilepsies

  2018cites this paper
• Novel in-frame deletion in MFSD8 gene revealed by trio whole exome sequencing in an Iranian affected with neuronal ceroid lipofuscinosis type 7: a case report

  2018cites this paper
• Occurrence and characterization of lipofuscin and ceroid in human atherosclerotic plaque

  2018cites this paper
• Characteristics of PPT1 and TPP1 enzymes in neuronal ceroid lipofuscinosis (NCL) 1 and 2 by dried blood spots (DBS) and leukocytes and their application to newborn screening.

  2018cites this paper
• Aspetti genetici delle epilessie

  2018cites this paper
• An Overview of the Role of Lipofuscin in Age-Related Neurodegeneration

  2018cites this paper
• Could Proteomics Become a Future Useful Tool to Shed Light on the Mechanisms of Rare Neurodegenerative Disorders?

  2018cites this paper
• Searching for novel biomarkers using a mouse model of CLN3-Batten disease

  2018cites this paper
• An Adapted Clinical Measurement Tool for the Key Symptoms of CLN2 Disease

  2018cites this paper
• Translating preclinical models of neuronal ceroid lipofuscinosis: progress and prospects

  2017cites this paper
• A tailored mouse model of CLN2 disease: A nonsense mutant for testing personalized therapies

  2017cites this paper
• The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer's Disease

  2017cites this paper
• Recent advances in applying mass spectrometry and systems biology to determine brain dynamics

  2017cites this paper
• GDE2 is essential for neuronal survival in the postnatal mammalian spinal cord

  2017cites this paper
• ABCA4 Mutation in a Patient With Juvenile Neuronal Ceroid Lipofuscinosis

  2017cites this paper
• Ocular Manifestations of Inborn Errors of Metabolism

  2017cites this paper
• A Short Commentary of Neuronal Ceroid Lipofuscinoses; Phenotypes inCongenital to Preschooler

  2017cites this paper
• The Eye in Pediatric Systemic Disease

  2017influential citation
• Retinal function in patients with the neuronal ceroid lipofuscinosis phenotype.

  2017cites this paper
• Juvenile NCL (CLN3 Disease): Emerging Disease-Modifying Therapeutic Strategies.

  2016cites this paper
• Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis

  2016influential citation
• Chorea in Late-Infantile Neuronal Ceroid Lipofuscinosis: An Atypical Presentation.

  2016cites this paper